Pharmaceutical

EnableComp Ranked #1 Specialty RCM Vendor for Complex Claims & Revenue Integrity Solutions by Hospital Financial Executives, Black Book 2025 Survey

Specialty RCM Adoption Surges as Providers Seek Automated Solutions to Rising Claim Complexity, Regulatory Pressure and Revenue Leakage NEW YORK...

HMNC Brain Health Announces Phase 2 Results from OLIVE Trial in Major Depressive Disorder (MDD) with Genetically Guided Precision Approach

BH-200 (nelivaptan) achieved clinically meaningful reduction in depressive symptoms across the full study population (Difference between BH-200 and placebo in...

error: Content is protected !!